David J. Main

2016

In 2016, David J. Main earned a total compensation of $1.3M as Chief Executive Officer and President at Aquinox Pharmaceuticals, a 17% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$195,500
Option Awards$663,030
Salary$460,000
Total$1,318,530

Main received $663K in option awards, accounting for 50% of the total pay in 2016.

Main also received $195.5K in non-equity incentive plan and $460K in salary.

Rankings

In 2016, David J. Main's compensation ranked 6,878th out of 14,075 executives tracked by ExecPay. In other words, Main earned more than 51.1% of executives.

ClassificationRankingPercentile
All
6,878
out of 14,075
51st
Division
Manufacturing
2,578
out of 5,486
53rd
Major group
Chemicals And Allied Products
842
out of 1,900
56th
Industry group
Drugs
648
out of 1,543
58th
Industry
Pharmaceutical Preparations
513
out of 1,173
56th
Source: SEC filing on March 26, 2018.

Main's colleagues

We found two more compensation records of executives who worked with David J. Main at Aquinox Pharmaceuticals in 2016.

2016

Abigail Jenkins

Aquinox Pharmaceuticals

Chief Commercial Officer and U.S. Business Head

2016

Kamran Alam

Aquinox Pharmaceuticals

Chief Financial Officer

News

In-depth

You may also like